Evaluation of the VITEK 2 system for identification and antimicrobial susceptibility testing of medically relevant gram-positive cocci.
about
Drug susceptibility testing of clinical isolates of streptococci and enterococci by the Phoenix automated microbiology system.Comparison of the MicroScan, VITEK 2, and Crystal GP with 16S rRNA sequencing and MicroSeq 500 v2.0 analysis for coagulase-negative Staphylococci.Erroneous reporting of coagulase-negative Staphylococci as Kocuria spp. by the Vitek 2 systemUse of the MicroSeq 500 16S rRNA gene-based sequencing for identification of bacterial isolates that commercial automated systems failed to identify correctly.Streptococcal toxic-shock syndrome due to Streptococcus dysgalactiae subspecies equisimilis in breast cancer-related lymphedema: a case reportDevelopment of a new oligonucleotide array to identify staphylococcal strains at species level.High prevalence of VanA-type vancomycin-resistant Enterococci in Austrian poultry.Low risk despite high endemicity of methicillin-resistant Staphylococcus aureus infections following elective total joint arthroplasty: a 12-year experience.Bacterial nanoscale cultures for phenotypic multiplexed antibiotic susceptibility testingTwo-center collaborative evaluation of the performance of the BD Phoenix automated microbiology system for identification and antimicrobial susceptibility testing of Enterococcus spp. and Staphylococcus spp.Direct detection and drug-resistance profiling of bacteremias using inertial microfluidicsMicrobiological evaluation of the new VITEK 2 Neisseria-Haemophilus identification card.Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA).Bacterial Cytological Profiling (BCP) as a Rapid and Accurate Antimicrobial Susceptibility Testing Method for Staphylococcus aureus.Evaluation of the automated phoenix system for potential routine use in the clinical microbiology laboratory.Performance of MALDI biotyper compared with Vitek™ 2 compact system for fast identification and discrimination of Staphylococcus species isolated from bovine mastitis.Comparative study using various methods for identification of Staphylococcus species in clinical specimens.Use of the Phoenix automated system for identification of Streptococcus and Enterococcus spp.History and evolution of antibiotic resistance in coagulase-negative staphylococci: Susceptibility profiles of new anti-staphylococcal agents.Use of the VITEK 2 system for rapid identification of clinical isolates of Staphylococci from bloodstream infections.Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci.Evaluation of the BD PHOENIX automated microbiology system for detection of methicillin resistance in coagulase-negative staphylococci.Comparison of methods for the identification of microorganisms isolated from blood cultures.Pitfalls in the identification of Enterococcus species and the detection of vanA and vanB genes.Performance of the new VITEK 2 GP card for identification of medically relevant gram-positive cocci in a routine clinical laboratory.Coherent Fluctuation Nephelometry: A Rapid Method for Urine Screening for Bacterial Contamination.Performance of MicroScan WalkAway and Vitek 2 for detection of oxacillin resistance in a set of methicillin-resistant Staphylococcus aureus isolates with diverse genetic backgrounds.Evaluation of the Vitek 2 system with a variety of Staphylococcus species.Validation of VITEK 2 version 4.01 software for detection, identification, and classification of glycopeptide-resistant enterococci.Extended-spectrum Beta-lactamase detection with different panels for automated susceptibility testing and with a chromogenic medium.Identification of clinically relevant viridans group streptococci by phenotypic and genotypic analysis.Evaluation of the BD Phoenix Automated Microbiology System for identification and antimicrobial susceptibility testing of common clinical isolates.High-throughput microarray for antimicrobial susceptibility testing.Comparison of 16S rRNA sequencing with conventional and commercial phenotypic techniques for identification of enterococci from the marine environment.Comparison of workflow and accuracy of identification and antimicrobial susceptibility testing of clinical isolates of Enterobacteriaceae, Pseudomonas aeruginosa and enterococci by Vitek 2 and routine methods.Novel vancomycin-peptide conjugate as potent antibacterial agent against vancomycin-resistant
P2860
Q33285554-ACCD6449-FE95-4F20-8466-75013726B742Q33395481-9FE8F1FB-1F75-4175-84A5-5D25150E7D03Q33752792-CB521A98-2954-42D6-8805-9D9DC0278E78Q33824645-595C80BE-9407-48F5-9F60-500F3552B485Q33909010-032B5958-C156-4541-829E-D0D3707C8C61Q34041512-A4C8010F-A9CA-48A5-AD85-8EBBB1E357F1Q34098077-5C91F0BF-1378-4293-A76C-A492A5402A1EQ34166902-89C3CD2D-1FEC-43E0-8B0D-9532865E90B9Q34427614-D353AE86-22A4-4302-9475-0CEC85A1455EQ34774262-8F6885D5-954E-424F-9DCF-8F3CF2DCDF6EQ35624778-C5E02F0B-3402-48F0-B90B-03C28228AC24Q36314403-7D2A4020-DF0C-486B-B017-E354C024262DQ36315377-7D234CD6-D572-45C9-A597-FF39D385A7CEQ36645037-F7EE98E8-368E-4F7A-A852-A931DB93FF61Q37419949-6DF8D63D-5088-4C75-9A0E-75968017A2AEQ37572863-04AEC789-2F81-4A0F-A7D1-0DA161FF81B3Q38473070-A45DA734-BFAD-47EC-943E-26A0E3D8654CQ38474671-773CB78D-2EC3-4E89-98C6-06AE16CC7E6CQ38536137-226472D8-3C6A-4E67-8718-B93B589B5A3BQ39887186-B580AF9F-8A16-4868-9559-D1E5F0B7E53DQ40133451-3213FDFF-27D4-4CE7-9E76-3BEED5CA91A7Q40282607-E7E1FD8B-2DE5-42AE-B58C-B1EE777DA81CQ40586541-B62A1285-50F8-43C0-BCDC-4F0E24B79633Q40628680-9C2D9307-47F0-479A-BBFF-A03888BCB386Q40770354-F83FA13F-E05E-49F8-AEFC-F20CA85FE46BQ41193831-98FE3CB7-8BF8-4E7C-8D8D-4180C220CB60Q41810327-AF0C9374-DAEC-4577-AEA5-544A268F917EQ41904521-5DB6F4B5-408E-4296-A23A-29881E67DB3AQ43186672-381BC878-80F6-41C7-8171-C8C2D5F6ED6BQ43248345-5B2D8C85-CB5C-4C8C-928A-C5A570745F77Q43510261-A7DCC744-5419-435D-A971-1BD573095F1AQ46551794-170531F6-CAE4-46C2-A577-58C861A5A476Q47130967-CF7F3ADD-DE4F-4077-BBDA-A41998CD674EQ51941829-258576BD-6348-4800-8934-484DBC50E35DQ54470008-71111889-D44A-4146-A9FF-F279E1143B87Q57815402-75A51F46-BFF7-428D-8266-F269AECEA471
P2860
Evaluation of the VITEK 2 system for identification and antimicrobial susceptibility testing of medically relevant gram-positive cocci.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Evaluation of the VITEK 2 syst ...... relevant gram-positive cocci.
@ast
Evaluation of the VITEK 2 syst ...... relevant gram-positive cocci.
@en
Evaluation of the VITEK 2 syst ...... relevant gram-positive cocci.
@nl
type
label
Evaluation of the VITEK 2 syst ...... relevant gram-positive cocci.
@ast
Evaluation of the VITEK 2 syst ...... relevant gram-positive cocci.
@en
Evaluation of the VITEK 2 syst ...... relevant gram-positive cocci.
@nl
prefLabel
Evaluation of the VITEK 2 syst ...... relevant gram-positive cocci.
@ast
Evaluation of the VITEK 2 syst ...... relevant gram-positive cocci.
@en
Evaluation of the VITEK 2 syst ...... relevant gram-positive cocci.
@nl
P2093
P2860
P1476
Evaluation of the VITEK 2 syst ...... relevant gram-positive cocci.
@en
P2093
Cinzia Bernini
Jessica Zuliani
Marco Ligozzi
Maria De Fatima
Maria Grazia Bonora
Roberta Fontana
P2860
P304
P356
10.1128/JCM.40.5.1681-1686.2002
P407
P577
2002-05-01T00:00:00Z